Keyphrases
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
95%
COVID-19
83%
COVID-19 Symptoms
40%
Emergency Department
17%
Adverse Outcomes
17%
Patients with COVID-19
17%
COVID-19 Mortality
17%
Risk Stratification
16%
Point-of-care
16%
COVID Symptoms
14%
BD Veritor
14%
Prospective Cohort Study
14%
Right-sided Infective Endocarditis
14%
Type 1 Diabetes Mellitus (T1DM)
14%
National Cohort Study
14%
Selective Serotonin Reuptake Inhibitors
14%
Patients with Diabetes
14%
Hyperglycemia
14%
Inflammation
14%
Prognostic Biomarker
14%
Throat Swab
14%
Clinical Validation
14%
Invasiveness
14%
Acute Care Surgery
14%
Medical Patients
14%
Antigen Test
14%
Venous Thromboembolism
14%
Infective Endocarditis
14%
Hospitalized Patients
14%
Early Discharge
14%
Postoperative Mortality
14%
Mechanical Ventilation
13%
D-dimer
9%
Nucleic Acid Amplification Test
9%
Mitral Valve
9%
Aortic Valve
9%
Confidence Interval
8%
Respiratory Failure
8%
Right-sided
7%
Disease Trajectory
7%
Positive Predictive Value
6%
C-reactive Protein
6%
Left-handed
5%
Medicine and Dentistry
COVID-19
100%
Urokinase Receptor
93%
Symptom
58%
Severe Acute Respiratory Syndrome Coronavirus 2
34%
Biological Marker
24%
Emergency Department
17%
Adverse Outcome
17%
Severe Acute Respiratory Syndrome
16%
Risk Stratification
16%
Hyperglycemia
14%
Throat Culture
14%
Acute Renal Failure
14%
COVID-19 Mortality
14%
Nucleic Acid Amplification
14%
Diabetes Mellitus
14%
Venous Thromboembolism
14%
Surgical Mortality
14%
Selective Serotonin Reuptake Inhibitor
14%
Prospective Cohort Study
14%
Infective Endocarditis
14%
Artificial Respiration
13%
D-Dimer
9%
Disease
9%
Respiratory Failure
8%
C Reactive Protein
6%
Infection
6%
Mitral Valve
5%
Proportional Hazards Model
5%
Hazard Ratio
5%
Pharmacology, Toxicology and Pharmaceutical Science
Urokinase Receptor
78%
Symptom
43%
Disease
37%
Coronavirinae
29%
SARS Coronavirus
25%
Biological Marker
22%
Adverse Outcome
17%
Inflammation
15%
Diabetes Mellitus
14%
Venous Thromboembolism
14%
Selective Serotonin Reuptake Inhibitor
14%
Hyperglycemia
14%
Prospective Cohort Study
14%
D Dimer
9%
Respiratory Failure
8%
